Fluid Resuscitation Protocol in Acute Pancreatitis

Preferred Fluid

• LR has demonstrated lower C-reactive protein levels (anti-inflammatory effect)
• Large volumes of NS cause hyperchloremic metabolic acidosis, which activates trypsinogen, making acinar cells more prone to injury and worsening SIRS
• LR may provide direct anti-inflammatory benefits through its lactate buffering
• Colloids are not recommended over crystalloids; colloid use is only considered if hematocrit falls below 24% or albumin drops below 2 g/dL

The Time-Based Protocol

Resuscitation Targets (All Time Points)

First 24 Hours - Aggressive Resuscitation Phase

• Pancreatic necrosis (from hypoperfusion)
• SIRS and organ failure
• ICU admission rates
• Need for invasive interventions

1. Initial bolus: 1-2 L of LR over 30-60 minutes (15-20 mL/kg bolus = approximately 1050-1400 mL in a 70 kg patient)
2. Maintenance rate: 250-500 mL/hour (ACG recommendation) OR 5-10 mL/kg/hour (IAP/APA goal-directed recommendation)
3. Total first-24-hour volume: typically 2500-4000 mL is required in most patients
4. Patients with severe volume depletion, significant tachycardia, or hypotension may need more rapid infusion
5. Monitoring: Hematocrit and BUN every 8-12 hours; vitals continuous or every 2-4 hours; strict urine output measurement (Foley catheter mandatory)
6. A fall in hematocrit and BUN within the first 12-24 hours is strong evidence of adequate resuscitation

Note: Overly aggressive fluid therapy (historically up to 20 mL/kg/hour) has been shown to increase risk of fluid overload, acute lung injury, and abdominal compartment syndrome. A recent RCT showed that the traditional aggressive strategy increased fluid overload risk compared to a moderate-intensity strategy (10 mL/kg bolus then 1.5 mL/kg/hour) without improving outcomes.

24-48 Hours - Reassessment and Goal-Directed Phase

1. Continue LR at a rate titrated to resuscitation targets
2. Reduce rate if resuscitation goals are being met (HR < 120, MAP adequate, urine output > 0.5-1 mL/kg/hr) to avoid fluid overload
3. Reassess every 6-8 hours with bedside clinical evaluation (vitals, O₂ saturation, physical exam)
4. Monitor for volume overload signs: tachypnea, hypoxia, lower extremity edema, pleural effusion on CXR
5. Rising BUN at this stage signals ongoing inadequate hydration AND is independently associated with higher in-hospital mortality
6. Patients with persistent tachycardia, hypotension, or oliguria require escalation to ICU with invasive hemodynamic monitoring
7. For severe acute pancreatitis: target CVP 8-12 mmHg, mixed venous O₂ saturation ≥ 70%
8. Consider CT scan after 48-72 hours if not improving to assess for pancreatic necrosis

48-72 Hours - Transition Phase

1. If patient is stabilizing (vitals normalized, urine output adequate, falling BUN/hematocrit), begin tapering IV fluid rate
2. Introduce early enteral nutrition - do not wait for lipase normalization; current guidelines recommend oral feeding within 24-48 hours in mild-moderate cases when tolerated
3. Continue monitoring for signs of fluid overload; diuresis may be appropriate once the initial hypovolemia has resolved
4. If not improving: CT with IV contrast should be performed to assess for necrosis
5. Persistent organ failure beyond 48 hours defines severe acute pancreatitis and warrants continued aggressive ICU-level management

Beyond 72 Hours - Maintenance and Weaning Phase

1. Transition from IV fluids to enteral/oral intake as tolerated
2. Mild-to-moderate disease: most patients should be tolerating oral liquids or a low-fat solid diet by this point
3. Severe/necrotizing pancreatitis: continue hemodynamic monitoring; nasojejunal tube feeding is preferred over parenteral nutrition
4. Parenteral nutrition (TPN) is reserved for patients who cannot tolerate oral or nasojejunal feeds within 5-7 days of admission
5. Avoid prophylactic antibiotics unless infected necrosis is documented (positive FNA culture or clinical/radiographic deterioration)
6. If fever, rising WBC, or hemodynamic deterioration occurs: consider infected pancreatic necrosis - obtain FNA culture, start carbapenems (better pancreatic penetration than cephalosporins or fluoroquinolones)

Summary Table

Management Algorithm (Maingot's)

Recent Evidence Update (2023-2025)

• LR vs. NS: Multiple 2024-2025 meta-analyses confirm LR reduces progression to moderate-to-severe acute pancreatitis compared to NS (PMID: 40085761)
• A 2023 systematic review confirmed that early, goal-directed resuscitation within the first 24-48 hours improves outcomes, but that the optimal volume strategy remains an area of active research (PMID: 37689561)
• The WATERFALL RCT (referenced in Harrison's 22E, 2025) showed that moderate-intensity hydration (10 mL/kg bolus + 1.5 mL/kg/hr) was non-inferior to aggressive hydration but with significantly less fluid overload - this has shifted recent guidelines toward goal-directed rather than blanket aggressive protocols